Long-term outcome of treatment for ann arbor Stage 1 Hodgkin's disease: Patterns of failure, late toxicity and second malignancies

This publication has 36 references indexed in Scilit:

• Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation
  Radiotherapy and Oncology, 1995
• Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Second solid tumors and leukemia after treatment for Hodgkin's disease: An analysis of 1121 patients from a single institution
  International Journal of Radiation Oncology*Biology*Physics, 1994
• Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: Evidence of a more difficult rescue for patients relapsed after chemotherapy
  European Journal Of Cancer, 1992
• Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
  Journal of Clinical Oncology, 1992
• Coronary artery disease mortality in patients treated for hodgkin's disease
  Cancer, 1992
• The EORTC trials for limited stage Hodgkin's disease
  European Journal Of Cancer, 1992
• Pericarditis and myocardial infarctions after Hodgkin's disease therapy
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy.
  Journal of Clinical Oncology, 1987
• Clinical versus Pathologic Stage I and II Hodgkin’s Disease
  Oncology, 1980